Frederick Locke

Department Chair, Blood and Marrow Transplant and Cellular Immunotherapy

Moffitt Cancer Center · Tampa, United States

About

Pioneering cell therapy researcher at Moffitt. Instrumental in the development and clinical investigation of CAR-T therapies for MCL and other lymphomas.

Specialties

CAR-T therapyCell therapyTransplant

Key Trials

ZUMA-2

Publications (2)

Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.

Blood advances · Oct 28, 2025

Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality.

Blood advances · Apr 23, 2024

Profile

https://moffitt.org/providers/frederick-locke/